Cargando…
Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A
BACKGROUND: New therapeutic drugs are urgently needed against visceral leishmaniasis because current drugs, such as pentavalent antimonials and miltefosine, produce severe side effects and development of resistance. Whether cyclosporine A (CsA) and its derivatives can be used as therapeutic drugs fo...
Autores principales: | Zheng, Zhi-Wan, Li, Jiao, Chen, Han, He, Jin-Lei, Chen, Qi-Wei, Zhang, Jian-Hui, Zhou, Qi, Chen, Da-Li, Chen, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035640/ https://www.ncbi.nlm.nih.gov/pubmed/32085719 http://dx.doi.org/10.1186/s13071-020-3958-x |
Ejemplares similares
-
Cedrus deodara: In vitro antileishmanial efficacy & immumomodulatory activity
por: Narayan, Shyam, et al.
Publicado: (2017) -
Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin‐Triazole Hybrids
por: Zuma, Nonkululeko H., et al.
Publicado: (2022) -
Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
por: Gavériaux, C., et al.
Publicado: (1989) -
Antileishmanial Anthracene Endoperoxides: Efficacy In Vitro, Mechanisms and Structure-Activity Relationships
por: Machin, Laura, et al.
Publicado: (2022) -
In Vitro and In Silico Evaluations of the Antileishmanial Activities of New Benzimidazole-Triazole Derivatives
por: Eser, Mustafa, et al.
Publicado: (2023)